Brief: Aptorum Group Announces Further Positive Interim Results Of Phase 1 Clinical Trial Of ALS-4

Aptorum

12/07/2021 13:10

July 12 (Reuters) - Aptorum Group Ltd  APM.O :
    * APTORUM GROUP ANNOUNCES FURTHER POSITIVE INTERIM RESULTS
OF THE
PHASE 1 CLINICAL TRIAL OF ALS-4 TARGETING STAPHYLOCOCCUS AUREUS

Source text for Eikon:  ID:nBw1wCVdBa 
Further company coverage:  APM.O 

 ((Reuters.Briefs@thomsonreuters.com;))